$ARVN
Arvinas, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New Haven, CT
ARVN chart
What traders are saying about $ARVN
Latest postsArvinas, Inc. news
- Arvinas introduces Early Career Researcher Award with 25000 grant for targeted protein degradation
Traders Union ·
- Arvinas Announces Return of Early Career Researcher Award to Recognize Innovation in Targeted Protein Degradation
Yahoo Finance ·
- After Its Vepinu Windfall, Arvinas Must Show A Thinner Pipeline Can Still Deliver
Finviz ·
- Arvinas to Report Third Quarter 2026 Financial Results on November 3, 2026
Yahoo Finance ·
- At 8 a.m. ET on Nov. 3, Arvinas will discuss its third-quarter results live.
Stock Titan ·
- What Arvinas Holders Got Wrong Before The Slide
Simply Wall Street ·
- Could You Have Seen The Run In Kymera Stock Coming?
trefis.com ·
- Arvinas, Inc. Estimates – NASDAQ:ARVN
TradingView ·
- ARVN Stock Drops On CEO Exit — Retail Is Bullish On New Chief’s Credentials, Dismisses Selloff
Stocktwits ·
- Arvinas (ARVN) Slips 1.37% to $7.55 as Shares Trade Near Lower Half of Range - Covered Call Trade
https://www.dars.gov.et/ ·
- Can KYMR's Targeted Protein Degradation Pipeline Drive Future Growth?
Yahoo Finance ·
- Roche Gets FDA Approval for Enspryng in Thyroid Eye Disease
Yahoo Finance ·
Arvinas, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $262.6M | $263.4M | $78.5M | $131.4M |
| Net income | -$81.0M | -$199.0M | -$367.0M | -$283.0M |
| Diluted EPS | $-1.14 | $-2.77 | $-6.62 | $-5.31 |
| Total assets (year end) | $717.9M | $1.09B | $1.30B | $1.27B |
| Cash and equivalents (year end) | $142.9M | $100.5M | $311.7M | $81.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Arvinas, Inc.
- Ticker
- ARVN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New Haven, CT
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1655759
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
Frequently asked questions
What exchange is Arvinas, Inc. listed on?
Arvinas, Inc. trades on the Nasdaq under the ticker symbol ARVN.
What industry is Arvinas, Inc. in?
Arvinas, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Arvinas, Inc. headquartered?
Arvinas, Inc.'s business address on file with the SEC is in New Haven, CT.
When does Arvinas, Inc.'s fiscal year end?
Arvinas, Inc.'s fiscal year ends on December 31.
How much revenue did Arvinas, Inc. report?
Arvinas, Inc. reported $262.6M in revenue for calendar year 2025, according to its SEC filings.